alexa Pharmacovigilance in India | Open Access Journals
ISSN: 2329-6887
Journal of Pharmacovigilance
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Pharmacovigilance in India

Jagadevappa S Patil*
SVERI’s College of Pharmacy, Maharashtra, India
Corresponding Author : Jagadevappa S Patil
Principal, SVERI’s College of Pharmacy, P.B. No. 54
Gopalpur-Ranjani Road, Pandharpur-413 304, Maharashtra, India
Tel: +91-8352 262770
E-mail: [email protected]
Received June 07, 2014; Accepted June 10, 2014; Published June 17, 2014
Citation: Patil JS (2014) Pharmacovigilance in India. J Pharmacovigilance 2:e119. doi: 10.4172/2329-6887.1000e119
Copyright: © 2014 Patil JS. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Journal of Pharmacovigilance

Pharmacovigilance concept has witnessed marvelous development worldwide within this decade. Public health care system in India is in sole control of the people who practice medicine. Literally Pharmacy practice system is not existent. There is an urgent need for the country to give preference for establishing Pharmacy practice system in the health care sector. To make Indian public health care system more effective and meaning full, country need Pharmacovigilance centre in order to address the problems related with occurrence of adverse drug reaction and other similar issues. Pharmacovigilance centre helps to derive the data related with aforementioned issues and in turn will give way for framing the national regulatory decisions. These measures definitely help drug regulatory authorities, physicians, pharmacists, patients and pharmaceutical companies to deliver effective duty in order to upgrade the quality of health care area in the country. India has got few highly reputed national Pharmaceutical institutes and number of private Pharmaceutical institutes of repute. It also has got national health authority and drug regulatory agency. However, any such organizations involved in clinical related research activity can be considered as suitable starting point for pharmacovigilance centers.
Pharmacovigilance is not a mere center but it is a process which requires a broad vision, dedication in its function, sufficient time to address the issues and competent expertise and restlessness continuity. The adverse drug reaction reporting programme can be developed step wise starting in any local hospital and extend it as a national activity. These centers should be shouldered to take care about prevention of prevention of drug induced human suffering and to avoid financial risks associated with unexpected adverse effects.
History of Pharmacovigilance in India
The history of adverse drug reaction monitoring system in India can be traced back to 1982, wherein five centers were established by Drug Controller General of India for nationwide monitoring of Adverse drug Reaction. It worked up to 1987 and where after stopped due to many reasons. Perhaps, the present plan may become successful as if it is structured based on previous lacuna. India is the fourth largest pharmaceutical producer in the world and recognizing as an important Clinical trial hub in the world. Due to introduction of many new drugs in the country necessitated to start a vibrant pharmacovigilance system in order to protect interest of public health. The main function of this programme involves data collection, analyzing it. Based on the inferences it can be recommended to regulatory interventions, besides communicating risks to healthcare professionals and the public.
Due to complexity associated with availability of multiple new drugs in the country every health care professional must have knowledge about the importance of adverse drug reaction reporting monitoring and pharmacovigilance. Hence, pharmacovigilance centre is necessary for continuous monitoring of marketed medicines in India.
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11613
  • [From(publication date):
    June-2014 - Jul 25, 2017]
  • Breakdown by view type
  • HTML page views : 7816
  • PDF downloads :3797

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version